| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | sarcosine | 63530.78 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | sarcosine | 63677.2 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | sarcosine | 64778.37 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | sarcosine | 66256.88 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | sarcosine | 67066.06 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | sarcosine | 69550.81 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | sarcosine | 71316.48 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | sarcosine | 72407.71 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | sarcosine | 76220.58 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | sarcosine | 77940.15 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | sarcosine | 82882.39 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | sarcosine | 83698.2 | Peak area (top) | ML210 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|